Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Adolor in-licenses Roberts compound for narcotic-induced constipation

June 18, 1998

Genome Therapeutics and Astra Research Center Boston extend alliance

June 17, 1998

ISIS-2302 exhibits promising activity in phase II study for Crohn's disease

June 17, 1998

Shiseido presents antisecretory/antibacterial agents for ulcers

June 16, 1998

Isis and Merck & Co. establish collaboration for hepatitis C

June 15, 1998

Protein Design Labs' human antihepatitis B antibody enters phase IIa

June 12, 1998

Maxamine plus IFN-alpha appears effective and safe in nonresponding HCV patients

June 11, 1998

First European clearance for Eisai's Pariet

June 11, 1998

Rebetron now available in the U.S.

June 9, 1998

Chinese herbal medicine reduces ALT levels in chronic hepatitis C

June 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...